Early data suggests monoclonal antibody therapies may reduce hospitalizations in people at high risk for severe COVID-19 complications by 70%. Limited supplies are now available in Western North Carolina.
![MAHEC COVID-19 antibody tent](https://mountainx.com/wp-content/uploads/2021/02/PXL_20210113_134014128.PORTRAIT-330x248.jpg)
Early data suggests monoclonal antibody therapies may reduce hospitalizations in people at high risk for severe COVID-19 complications by 70%. Limited supplies are now available in Western North Carolina.